Significance of Cellular Senescence in Aging and Cancer

키워드

참고문헌 (97)

1. Smith JR, "Replicative senescence: implications for in vivo aging and tumor suppression", Science, 273, pp.63~67 (1996)
2. Krtolica A, "Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging", Proc Natl Acad Sci U S A, 98, pp.12072~12077 (2001)
3. Cotter MA, "Absence of senescence-associated β‚-galactosidase activity in human melanocytic nevi in vivo", J Invest Dermatol, 127, pp.2469~2471 (2007)
4. Ben-Porath I, "When cells get stressed: an integrative view of cellular senescence", J Clin Invest, 113, pp.8~13 (2004)
5. de Magalhaes JP, "From cells to ageing: a review of models and mechanisms of cellular senescence and their impact on human ageing", Exp Cell Res, 300, pp.1~10 (2004)
6. Sandhu AK, "Senescence of immortal human fibroblasts by the introduction of normal human chromosome 6", Proc Natl Acad Sci U S A, 91, pp.5498~5502 (1994)
7. Itahana K, "Mechanisms of cellular senescence in human and mouse cells", Biogerontology, 5, pp.1~10 (2004)
8. Mooi WJ, "Oncogene-induced cell senescence-halting on the road to cancer", N Engl J Med, 355, pp.1037~1046 (2006)
9. Braig M, "Oncogene-induced senescence as an initial barrier in lymphoma development", Nature, 436, pp.660~665 (2005)
10. Michaloglou C, "BRAFE600-associated senescence-like cell cycle arrest of human naevi", Nature, 436, pp.720~724 (2005)
11. Chen JH, "DNA damage, cellular senescence and organismal ageing: causal or correlative?", Nucleic Acids Res, 35, pp.7417~7428 (2007)
12. Berube NG, "The genetics of cellular senescence", Am J Hum Genet, 62, pp.1015~1019 (1998)
13. Sitte N, "Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I-- effects of proliferative senescence", FASEB J, 14, pp.2495~2502 (2000)
14. Campisi J, "Cellular senescence as a tumor-suppressor mechanism", Trends Cell Biol, 11, pp.S27~31 (2001)
15. Spencer CC, "Testing an 'aging gene' in longlived drosophila strains: increased longevity depends on sex and genetic Background", Aging Cell, 2, pp.123~130 (2003)
16. Campisi J, "Cancer and ageing: rival demons?", Nat Rev Cancer, 3, pp.339~349 (2003)
17. Hardy K, "Transcriptional networks and cellular senescence in human mammary fibroblasts", Mol Biol Cell, 16, pp.943~953 (2005)
18. Wright WE, "Cellular senescence as a tumor-protection mechanism: the essential role of counting", Curr Opin Genet Dev, 11, pp.98~103 (2001)
19. Patil CK, "The thorny path linking cellular senescence to organismal aging", Mech Ageing Dev, 126, pp.1040~1045 (2005)
20. Martinez DE, "Mortality patterns suggest lack of senescence in hydra", Exp Gerontol, 33, pp.217~225 (1998)
21. Campisi J, "tumor suppression, and organismal aging: good citizens, bad neighbors", Cell, 120, pp.513~522 (2005)
22. Narita M, "Cellular senescence and chromatin organization", Br J Cancer, 96, pp.686~691 (2007)
23. Parrinello S, "Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation", J Cell Sci, 118, pp.485~496 (2005)
24. Itahana K, "Regulation of cellular senescence by p53", Eur J Biochem, 268, pp.2784~2791 (2001)
25. Jackson JG, "p53 is preferentially recruited to the promoters of growth arrest genes p21 and GADD45 during replicative senescence of normal human fibroblasts", Cancer Res, 66, pp.8356~8360 (2006)
26. Seluanov A, "DNA end joining becomes less efficient and more error-prone during cellular senescence", Proc Natl Acad Sci U S A, 101, pp.7624~7629 (2004)
27. Sedelnikova OA, "Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks", Nat Cell Biol, 6, pp.168~170 (2004)
28. Shay JW, "Hallmarks of senescence in carcinogenesis and cancer therapy", Oncogene, 23, pp.2919~2933 (2004)
29. Vieira C, "Genotypeenvironment interaction for quantitative trait loci affecting life span in Drosophila melanogaster", Genetics, 154, pp.213~227 (2000)
30. Hughes KA, "A test of evolutionary theories of aging", Proc Natl Acad Sci U S A, 99, pp.14286~14291 (2002)
31. Hendry AP, "Adaptive variation in senescence: reproductive lifespan in a wild salmon population", Proc Biol Sci, 271, pp.259~266 (2004)
32. Leroi AM, "What evidence is there for the existence of individual genes with antagonistic pleiotropic effects?", Mech Ageing Dev, 126, pp.421~429 (2005)
33. Charmantier A, "Age-dependent genetic variance in a life-history trait in the mute swan", Proc Biol Sci, 273, pp.225~232 (2006)
34. Silbermann R, "Reproductive costs of heat shock protein in transgenic Drosophila melanogaster", Evolution, 54, pp.2038~2045 (2000)
35. Nuzhdin SV, "Sex-specific quantitative trait loci affecting longevity in Drosophila melanogaster", Proc Natl Acad Sci U S A, 94, pp.9734~9739 (1997)
36. Charlesworth B, "Age-specific inbreeding depression and components of genetic variance in relation to the evolution of senescence", Proc Natl Acad Sci U S A, 93, pp.6140~6145 (1996)
37. Swindell WR, "Inbreeding depression and male survivorship in Drosophila: Implications for senescence theory", Genetics, 172, pp.317~327 (2006)
38. Borash DJ, "Mutation accumulation affects male virility in Drosophila selected for later reproduction", Physiol Biochem Zool, 80, pp.461~472 (2007)
39. Nussey DH, "The rate of senescence in maternal performance increases with early-life fecundity in red deer", Ecol Lett, 9, pp.1342~1350 (2006)
40. Moorad JA, "A theory of age-dependent mutation and senescence", Genetics, 179, pp.2061~2073 (2008)
41. Lendvay TS, "Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes", Genetics, 144, pp.1399~1412 (1996)
42. Rheinwald JG, "A two-stage, p16 (INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status", Mol Cell Biol, 22, pp.5157~5172 (2002)
43. Ulaner GA, "Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts", Cancer Res, 58, pp.4168~4172 (1998)
44. Ning Y, "Telomere length and the expression of natural telomeric genes in human fibroblasts", Hum Mol Genet, 12, pp.1329~1336 (2003)
45. Gorbunova V, "Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis", J Biol Ch, 277, pp.38540~38549 (2002)
46. Ohmura H, "Restoration of the cellular senescence program and repression of telomerase by human chromosome 3", Jpn J Cancer Res, 86, pp.899~904 (1995)
47. Cosme-Blanco W, "Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence", EMBO Rep, 8, pp.497~503 (2007)
48. Karlseder J, "Senescence induced by altered telomere state, not telomere loss", Science, 295, pp.2446~2449 (2002)
49. d'Adda di Fagagna F, "A DNA damage checkpoint response in telomere-initiated senescence", Nature, 426, pp.194~198 (2003)
50. Goytisolo FA, "Many ways to telomere dysfunction: in vivo studies using mouse models", Oncogene, 21, pp.584~591 (2002)
51. Choudhury AR, "Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation", Nat Genet, 39, pp.99~105 (2007)
52. Hemann MT, "The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability", Cell, 107, pp.67~77 (2001)
53. Wei S, "Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts", Cancer Res, 59, pp.1539~1543 (1999)
54. Farwell DG, "Genetic and epigenetic changes in human epithelial cells immortalized by telomerase", Am J Pathol, 156, pp.1537~1547 (2000)
55. Li S, "Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutanttemplate telomerase RNA and anti-telomerase short-interfering RNA", Cancer Res, 64, pp.4833~4840 (2004)
56. Dickson MA, "Human keratinocytes that express hTERT and also bypass a p16 (INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics", Mol Cell Biol, 20, pp.1436~1447 (2000)
57. Feldser DM, "Short telomeres limit tumor progression in vivo by inducing senescence", Cancer Cell, 11, pp.461~469 (2007)
58. Deng Q, "High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts", J Biol Chem, 279, pp.1050~1059 (2004)
59. Zhang R, "Molecular dissection of formation of senescenceassociated heterochromatin foci", Mol Cell Biol, 27, pp.2343~2358 (2007)
60. Narita M, "Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence", Cell, 113, pp.703~716 (2003)
61. Passos JF, "Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere- dependent senescence", PLoS Biol, 5, pp.e110~ (2007)
62. Trifunovic A, "Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production", Proc Natl Acad Sci U S A, 102, pp.17993~17998 (2005)
63. de Haan JB, "Elevation in the ratio of Cu", Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide, 1996, pp.5, 283~292
64. Lee AC, "Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species", J Biol Chem, 274, pp.7936~7940 (1999)
65. Serrano M, "Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a", Cell, 88, pp.593~602 (1997)
66. Lin AW, "Premature senescence involving p53 and p16 is activated in response to constitutive MEK", MAPK mitogenic signaling, 1998, pp.12, 3008~3019
67. Pearson M, "PML regulates p53 acetylation and premature senescence induced by oncogenic Ras", Nature, 406, pp.207~210 (2000)
68. Di Micco R, "Oncogeneinduced senescence is a DNA damage response triggered by DNA hyper-replication", Nature, 444, pp.638~642 (2006)
69. Sarkisian CJ, "Dosedependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis", Nat Cell Biol, 9, pp.493~505 (2007)
70. Zhu J, "Senescence of human fibroblasts induced by oncogenic Raf", Genes Dev, 12, pp.2997~3007 (1998)
71. Dimri GP, "A novel biomarker identifies senescent human cells in culture and in aging skin in vivo", Proc Natl Acad Sci U S A, 92, pp.9363~9367 (1995)
72. Bartkova J, "Oncogeneinduced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints", Nature, 444, pp.633~637 (2006)
73. Sherr CJ, "Tumor surveillance via the ARF-p53 pathway", Genes Dev, 12, pp.2984~2991 (1998)
74. Lavin MF, "The complexity of p53 stabilization and activation", Cell Death Differ, 13, pp.941~950 (2006)
75. Xue W, "Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas", Nature, 445, pp.656~660 (2007)
76. Marusyk A, "p53 mediates senescence-like arrest induced by chronic replicational stress", Mol Cell Biol, 27, pp.5336~5351 (2007)
77. Feng L, "Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence", Cell Cycle, 5, pp.2812~2819 (2006)
78. Ferbeyre G, "Oncogenic ras and p53 cooperate to induce cellular senescence", Mol Cell Biol, 22, pp.3497~3508 (2002)
79. Sionov RV, "The cellular response to p53: the decision between life and death", Oncogene, 8, pp.6145~6157 (1999)
80. He X, "The guardian's little helper: microRNAs in the p53 tumor suppressor network", Cancer Res, 67, pp.11099~11101 (2007)
81. Bandyopadhyay D, "Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi", Aging Cell, 6, pp.577~591 (2007)
82. Lal A, "p16(INK4a) translation suppressed by miR-24", PLoS One, 3, pp.e1864~ (2008)
83. Beausejour CM, "Reversal of human cellular senescence: roles of the p53 and p16 pathways", EMBO J, 22, pp.4212~4222 (2003)
84. Kulaeva OI, "Epigenetic silencing of multiple interferon pathway genes after cellular immortalization", Oncogene, 22, pp.4118~4127 (2003)
85. Hara E, "Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence", Mol Cell Biol, 16, pp.859~867 (1996)
86. Crescenzi E, "Bcl-2 activates a programme of premature senescence in human carcinoma cells", Biochem J, 375, pp.263~274 (2003)
87. Lopez-Diazguerrero NE, "Bcl-2 protects against oxidative stress while inducing premature senescence", Free Radic Biol Med, 40, pp.1161~1169 (2006)
88. Keyes WM, "p63: a new link between senescence and aging", Cell Cycle, 5, pp.260~265 (2006)
89. Chang BD, "Effects of p21Waf1", Cip1, Proc Natl Acad Sci U S A, pp.2000, 97[DOI]
90. Mallette FA, "Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence", Oncogene, 23, pp.91~99 (2004)
91. Garcia-Cao I, ""Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally", EMBO J, 21, pp.6225~6235 (2002)
92. Matheu A, "Increased gene dosage of Ink4a", Arf results in cancer resistance and normal aging, 2004, pp.18, 2736~2746
93. Schmitt CA, "A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy", Cell, 109, pp.335~346 (2002)
94. te Poele RH, "DNA damage is able to induce senescence in tumor cells in vitro and in vivo", Cancer Res, 62, pp.1876~1883 (2002)
95. Kahlem P, "Cellular senescence in cancer treatment: friend or foe?", J Clin Invest, 113, pp.169~174 (2004)
96. Ventura A, "Restoration of p53 function leads to tumour regression in vivo", Nature, 445, pp.661~665 (2007)
97. Joerger AC, "Structure-function-rescue: the diverse nature of common p53 cancer mutants", Oncogene, 26, pp.2226~2242 (2007)

관련 논문AI추천